![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Quidel Influenza A+B Assay
FDA Clears Quidel Influenza A+B Assay
February 15, 2018
San Diego-based developer of diagnostic testing solutions Quidel received FDA clearance for its QuickVue Influenza A+B assay.
The assay allows for the rapid, qualitative detection of influenza type A and type B antigens directly in nasal swab and nasopharyngeal swab specimens, the company said.
It is designed to identify and differentiate between the two influenza viruses in about 10 minutes.
Upcoming Events
-
21Oct